Biodesix, Inc.BDSXNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P31
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -4.08% |
| Q3 2025 | -8.47% |
| Q2 2025 | 13.90% |
| Q1 2025 | 18.89% |
| Q4 2024 | -5.22% |
| Q3 2024 | -0.43% |
| Q2 2024 | 25.39% |
| Q1 2024 | 7.99% |
| Q4 2023 | -2.53% |
| Q3 2023 | -33.40% |
| Q2 2023 | -10.49% |
| Q1 2023 | -8.81% |
| Q4 2022 | 20.03% |
| Q3 2022 | -11.63% |
| Q2 2022 | 4.83% |
| Q1 2022 | 12.41% |
| Q4 2021 | -13.39% |
| Q3 2021 | -0.90% |
| Q2 2021 | 0.06% |
| Q1 2021 | 6.96% |
| Q4 2020 | 14.75% |
| Q3 2020 | 28.43% |
| Q2 2020 | -27.34% |
| Q1 2020 | 15.91% |
| Q4 2019 | 6.06% |
| Q3 2019 | -15.86% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |